North Korea accuses US of spreading Ebola and choosing Africa as a bio-weapon testing ground

KCNA called for the US to face a human rights trial

Heather Saul
Tuesday 02 December 2014 12:24
Comments

North Korea is accusing the US of spreading the Ebola virus, claiming it has been “bent on the development of bio-weapons” in order to achieve world supremacy.

The secretive state reacted strongly to the Ebola outbreak by closing its border to tourists and quarantining anyone who does enter.

Now, a report by the Korean Central News Agency (KCNA) is claiming an aide to ex-President Reagan informed them the US had invented a progenitor of Ebola virus “for the purpose of launching a biological warfare”.

The aide was named as Roberts, who The Washington Post said could be a reference to Paul Craig Roberts, an econmoist.

Mr Roberts recently published a blog post entitled ‘Is The US Government The Master Criminal Of Our Time?’ which cited work published by two academics on Ebola.

Only a few weeks after a UN resolution condemned the country’s human right’s record, The KCNA criticised the US for its own human rights record.

The article said the US had given $140 million (£89 million) to a pharmaceutical company for research into the virus and chose Africa as a bio-weapon testing ground. It credited this claim to an unnamed Liberian professor.

It also claimed that the “US Department of Health and Human Services” admitted that the US “imperialists” have long conducted “vivisections with fatal epidemics, inflicting untold sufferings on mankind”.

It added: “Russian, Singaporean and American newspapers criticised that the US developed anti-Ebola virus vaccine through experiment on Ebola contagion, but has prevented this vaccine from being known to the world, only for its own interests.”

It also went on to claim that the Aids pandemic was also created by the US. In one final accusation, it said: “As already known to everyone, the US is the world's biggest nuke possessor.”

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in